Navigation Links
Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
Date:4/4/2012

EAST SETAUKET, N.Y., April 4, 2012 /PRNewswire/ -- Lixte Biotechnology Holdings, Inc. announced receiving an official notice of allowance from the United States Patent and Trademark Office for its lead histone deacetylase inhibitor (HDACi), LB-201 and other structural homologs.

Dr. John Kovach, founder and president of Lixte, said, "Although there are HDACi approved for certain types of skin lymphomas and many other HDACi in various stages of development, our compounds have characteristics which may be advantageous for clinical use.  The Lixte compounds also have broad anti-cancer activity but in addition have 1) potential for the treatment of neurodegenerative diseases, for which Lixte recently announced a USPTO patent approval, 2) activity (LB-205) against the lysosomal storage disease, Gaucher Disease, as recently reported in the Proceedings of the National Academy of Science, USA (Dec. 27 2011; 108:21200-5) and 3) curative anti-fungal activity applied topically (LB-201) against the most common skin fungal infections of humans and domestic animals in guinea pig models. As Lixte is predominantly focused on cancer treatment, it is seeking to license the non-neoplastic activities of its proprietary HDACi."

Dr. Kovach continued, "Lixte's primary goal at present is bringing its lead anti-cancer compound, LB-100, into Phase I trial.  We believe this inhibitor of serine/threonine phosphatase has the potential to be first-in-class and to have wide applicability for the treatment of diverse cancers.  LB-100 has completed pre-clinical toxicology and formulation with an anticipated IND submission for FDA approval of a Phase I trial this spring."

About Lixte Biotechnology Holdings, Inc.

Lixte is a cancer drug discovery company, combining selection of novel targets from the medicinal chemistry and molecular biology literature with innovative synthetic chemistry to develop new potentially more effective anti-cancer drugs. It has l
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
2. Lixte Biotechnology Holdings Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models
3. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
4. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
5. Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004
6. Global Biotechnology Industry
7. JumpStart Invests $250,000 in Milo Biotechnology
8. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. Animal Biotechnology - Technologies, Markets and Companies
11. Puma Biotechnology Announces Completion of Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... CAMBRIDGE, Mass. , July 14, 2014 ... in the development of new therapies to treat neuropsychiatric ... Ahlholm has been appointed vice president of finance ... Mr. Ahlholm is a senior executive with more ... functions at technology and life science companies. His background ...
(Date:7/14/2014)... July 14, 2014 PatientCrossroads, ... platform, announced that three PatientCrossroads-based patient registries—DuchenneConnect, ... Phelan-McDermid Syndrome International Registry; and the NephCure ... awarded contracts by the Patient-Centered Outcomes Research ... of a new health data network called ...
(Date:7/13/2014)... discovery 30 years ago of soccer-ball-shaped carbon molecules called ... Now, there appears to be a new ball on ... and Tsinghua University in China have shown that a ... cage similar to a carbon buckyball. It,s the first ... matter of speculationdoes indeed exist. , "This is the ...
(Date:7/13/2014)... 2014 Deep Research Report on Global and China ... on the current state of the Nano Silver industry ... basic overview of the industry, including definitions, applications and ... market analysis are provided with a focus on history, ... comparison between the international and Chinese situation is also ...
Breaking Biology Technology:Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3
... Proprietary Products Division of Par Pharmaceutical with Initial Focus on ... ... WOODCLIFF LAKE, N.J., Sept. 28 /PRNewswire-FirstCall/ - Par,Pharmaceutical Companies, Inc. ... marketing novel prescription drugs, through the,establishment and introduction of Strativa ...
... Mass., Sept. 28 Idenix,Pharmaceuticals, Inc. (Nasdaq: ... the discovery and development of drugs for ... a strategic restructuring. As part of the,restructuring, ... Novartis,Pharma AG related to Tyzeka(R)/Sebivo(R). Per the ...
... NORCROSS, Ga., Sept. 28 Immucor, Inc.,(Nasdaq: ... providing automated instrument-reagent,systems to the blood transfusion ... Commission (SEC) has agreed to a complete,settlement ... the company,s Italian subsidiary. Under the ...
Cached Biology Technology:Introducing Strativa Pharmaceuticals 2Introducing Strativa Pharmaceuticals 3Introducing Strativa Pharmaceuticals 4Introducing Strativa Pharmaceuticals 5Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 3Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 4Immucor Settles SEC Investigation 2
(Date:7/14/2014)... could overcome a major cost barrier to make ... replace expensive and environmentally harmful fossil fuels. , ... performs almost as well as cost-prohibitive platinum for ... split water molecules into hydrogen and oxygen. The ... less-expensive catalysts investigated to-date. , "Hydrogen has long ...
(Date:7/14/2014)... to reliably and safely make in the laboratory all of ... key step closer to reality. , Writing today in the ... of Wisconsin-Madison stem cell researcher Igor Slukvin reports the discovery ... and turning them into both red and the array of ... is important because it identifies how nature itself makes blood ...
(Date:7/13/2014)... women suggests that experiencing one or more stressful events ... slow the body,s metabolism, potentially contributing to weight gain. ... stressors before giving them a meal consisting of 930 ... measured their metabolic rate how long it took ... took measures of blood sugar, triglycerides, insulin and the ...
Breaking Biology News(10 mins):Rutgers chemists develop technology to produce clean-burning hydrogen fuel 2Wisconsin scientists find genetic recipe to turn stem cells to blood 2Wisconsin scientists find genetic recipe to turn stem cells to blood 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4
... that clean water and air are signs of a healthy ... the environment is right beneath their feet, according to a ... maintaining a clean environment by serving as a natural water ... and soil hydrology. Understanding the components that make up this ...
... State of the Union address, President Obama singled out climate ... can choose to believe that Superstorm Sandy, and the most ... have ever seen were all just a freak coincidence," he ... judgment of science and act before it,s too late." ...
... shift in U.S. demographics and importance of minorities took ... those growing toward majority acquire representation in our educational ... and move minorities forward to majorities in science, technology, ... gaining traction, said Castillo-Chavez, one of a trio of ...
Cached Biology News:Key to cleaner environment may be right beneath our feet 2Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 2Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 3Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 4Going negative: Stanford scientists explore new technologies that remove atmospheric CO2 5Mentoring models to move minorities to majorities in STEM 2Mentoring models to move minorities to majorities in STEM 3
The F40 pump maintenance kit is used to service one F40 pump of a BioLogic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
... HDAC8 Regulation of gene expression ... as DNA methylation, ATP-dependent chromatin remodeling, ... which include the dynamic acetylation and ... residues present in the tail of ...
...
Mouse monoclonal antibody raised against a partial recombinant PUM2. NCBI Entrez Gene ID = PUM2...
Biology Products: